TDC
AHPI

Thompson Davis & Co’s Allied Healthcare Products AHPI Stock Holding History

Thompson Davis & Co’s Portfolio AHPI Stock Details AHPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,000
Closed -$17K – 115
2022
Q3 		$17K Buy
13,000
+3,000
+30% +$5.51K 0.02% 81
2022
Q2 		$16K Buy
+10,000
New +$22.7K 0.03% 92

Other funds holding AHPI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Thompson Davis & Co's AHPI Position: Q4 2022 in Review

Thompson Davis & Co sold out of Allied Healthcare Products (AHPI) in Q4 2022, closing a stake of 13,000 shares — an estimated $17K sold.

Thompson Davis & Co first reported a position in AHPI in Q2 2022 and held it in 2 quarters. The position peaked at $17K in Q3 2022. 12 funds tracked by Wall St. Rank hold AHPI as of Q4 2022.

  • Thompson Davis & Co reported no remaining Allied Healthcare Products position as of Q4 2022 after selling out during the quarter.
  • Thompson Davis & Co sold 13,000 Allied Healthcare Products shares in Q4 2022, an estimated $17K.
  • Thompson Davis & Co first reported a position in Allied Healthcare Products in Q2 2022 and held it in 2 quarters.
  • Thompson Davis & Co's Allied Healthcare Products position peaked at $17K in Q3 2022.
  • 12 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q4 2022.

Based on Thompson Davis & Co's 13F filing for Q4 2022, filed 6 Feb 2023.